21st Centry Oncolgy — Yonkers, New York

21st Centry Oncolgy is a clinical research site located in Yonkers, New York, United States 10457.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

21st Centry Oncolgy has participated in 1 clinical trials.

Therapeutic areas: Ductal Breast Carcinoma In Situ, Estrogen Receptor Positive, Invasive Breast Carcinoma.

Sponsors: Rutgers, The State University of New Jersey.

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for 21st Centry Oncolgy?

21st Centry Oncolgy has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has 21st Centry Oncolgy conducted?

21st Centry Oncolgy has 1 clinical trials on record. Their work covers Ductal Breast Carcinoma In Situ, Estrogen Receptor Positive, Invasive Breast Carcinoma.

Is 21st Centry Oncolgy accredited by Crixeo Health?

21st Centry Oncolgy has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about 21st Centry Oncolgy?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.